Thrombosis research, 2015-03, Vol.135 (3), p.568-570
2015
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Rivaroxaban as anticoagulant therapy in short bowel syndrome. Report of three cases
- Ist Teil von
- Thrombosis research, 2015-03, Vol.135 (3), p.568-570
- Ort / Verlag
- United States: Elsevier Ltd
- Erscheinungsjahr
- 2015
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Highlights • Patients with Short bowel syndrome need an alternative oral anticoagulation therapy. • We investigate rivaroxaban as an alternative anticoagulation therapy. • We find plasma concentration of rivaroxaban within the recommended levels after 20 mg OD. • We find that rivaroxaban may be an effective alternative to treatment with vitamin K antagonists.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0049-3848eISSN: 1879-2472DOI: 10.1016/j.thromres.2015.01.005Titel-ID: cdi_crossref_primary_10_1016_j_thromres_2015_01_005
- Format
- –
- Schlagworte
- Administration, Oral, Aged, Anticoagulants - administration & dosage, Anticoagulants - blood, Anticoagulants - therapeutic use, Female, Hematology, Oncology and Palliative Medicine, Humans, Male, Middle Aged, Rivaroxaban - administration & dosage, Rivaroxaban - blood, Rivaroxaban - therapeutic use, Short Bowel Syndrome - blood, Short Bowel Syndrome - complications, Thrombosis - blood, Thrombosis - prevention & control